István Puskás

Cantrixil’s Career Shift: Orphan Drug Encapsulated in Alpha-Cyclodextrin Changes Hands (and Cyclodextrin)

On 31 March, 2025, Kazia Therapeutics (Australia) Announced sale of intellectual property and trademarks rights for Cantrixil, a product that

Aside from its packaging design, “Phytocare α-CD 150g” does not specifically appear to be a cat-focused product. However, the inclusion

Assessing the stability of drugs in space is crucial for future missions due to various environmental factors such as radiation,

The U.S. Food and Drug Administration has approved Axsome Therapeutics’ new migraine treatment tablet on 30 January 2025 [1]. Marketed

Over the past decade, the growing threat of antibiotic resistance has intensified interest in antimicrobial peptides and lipopeptides as promising

Today’s cyclodextrin chef invites you on a flavorful world tour, showcasing the versatility of cyclodextrins in enhancing a variety of

Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX,

Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA

As Christmas approaches, the figures of three scientists also known as the Three Wise Men, Three Kings, and Three Magi

Discover the world inside your body and nurture your health from within! Japanese Meiji Co., Ltd., a leading innovator in